Cynosure and Hahn & Company, the recent acquirer of Lutronic, have formally announced a definitive merger agreement. This strategic combination marks a noteworthy partnership between two leading global entities in the sector, Cynosure and Lutronic. The transaction is expected to close in the first quarter of 2024, subject to customary closing conditions. The terms of the transaction were not disclosed. This strategic combination creates a global leader in medical aesthetic systems with a diversified, innovative product portfolio, and a commercial presence in more than 130 countries. The combined company offers customers and patients a broader product and consumables suite, a depth of related clinical training and services, expanded research and development capabilities, an enhanced geographic footprint to serve more customers around the world, and a reinforced supply chain to ensure seamless continuity of products and services. "The strategic combination will create a combined company with the resources, product portfolio and expertise that will benefit our customers, partners and employees," says Nadav Tomer, CEO of Cynosure. "We are thrilled that Cynosure is partnering with Lutronic as we believe this will create a distinct opportunity to combine two strong global players in energy-based medical device technology for aesthetics."